OKUR- Onkure Therapeutics, Inc.

Name: Onkure Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Onkure Therapeutics, Inc. (OKUR) has 13 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. OKUR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Acorn Bioventures, L.P.	1.71M	$6.69M	-
CEO	Saccomano Nicholas A	330.0K	$1.29M	-
Other	Agresta Samuel	110.0K	$430.1K	-
CFO	Leverone Jason A.	110.0K	$430.1K	-
Other	Hartley Dylan	110.0K	$430.1K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 23, 2026	Saccomano Nicholas A	President And CEO	Sell	86	$4.16	$357.46	-1.2%	-	-
Mar 23, 2026	Leverone Jason A.	Chief Financial Officer	Sell	301	$4.16	$1,251.11	-1.8%	-	-
Dec 22, 2025	Leverone Jason A.	Chief Financial Officer	Sell	302	$2.97	$896.25	-1.8%	+34.5%	-
Dec 22, 2025	Saccomano Nicholas A	President And CEO	Sell	87	$2.97	$258.19	-1.2%	+34.5%	-
Sep 22, 2025	Leverone Jason A.	Chief Financial Officer	Sell	303	$2.62	$794.92	-2.3%	+13.4%	-
Sep 22, 2025	Saccomano Nicholas A	President And CEO	Sell	88	$2.62	$230.87	-2.4%	+13.4%	-
Jun 23, 2025	Saccomano Nicholas A	President And CEO	Sell	88	$2.38	$209.81	-2.4%	+8.3%	-
Jun 23, 2025	Leverone Jason A.	Chief Financial Officer	Sell	303	$2.38	$722.41	-2.3%	+8.3%	-
May 15, 2025	Cormorant Asset Management, LP50	-	Sell	1,813,439	$1.85	$3,363,022.63	-100%	+16.5%	-
May 15, 2025	Acorn Bioventures, L.P.	10% Owner	Buy	1,400,000	$1.85	$2,590,000.00	+97.2%	+16.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC